Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares shot up 27.8% during trading on Wednesday . The stock traded as high as GBX 23 ($0.29) and last traded at GBX 23 ($0.29). 113,192 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 318,884 shares. The stock had previously closed at GBX 18 ($0.22).
Celadon Pharmaceuticals Stock Performance
The stock has a 50 day moving average of GBX 18.36 and a two-hundred day moving average of GBX 27.79. The stock has a market capitalization of £15.84 million, a PE ratio of -287.50 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a current ratio of 1.92 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Why Invest in 5G? How to Invest in 5G Stocks
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
